Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2026-03-01
Cyfres:	JEADV Clinical Practice
Pynciau:	atopic dermatitis biologics JAK inhibitors real‐world evidence
Mynediad Ar-lein:	https://doi.org/10.1002/jvc2.70153
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!